Aspen Laser and TheraLight Complete Corporate and Warehouse Expansion

Posted on

LINDON, Utah, June 28, 2024 /PRNewswire/ — Aspen Laser Systems, LLC, and TheraLight, LLC, two co-owned and co-operated, privately held U.S.-based medical device companies specializing in photomedicine, completed an expansion of their corporate headquarters and warehouse in Lindon, Utah, to advance the operations and growth of the company. The expansion, completed in April 2024, adds […]

Read More

Co-Diagnostics Expands Vector Control Customer Base to 25 Customers Across 15 U.S. States

Posted on

SALT LAKE CITY, July 2, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx™️️”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that use of the Company’s vector control technology will expand to the 15th U.S. state following an installation in Nevada next week. […]

Read More

Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors

Posted on

Epitel, a leader in AI technologies for patient-focused brain health solutions, announced today the addition of wearables industry pioneer Ken Nelson to its Board of Directors. With his extensive experience in digital health, medical devices, and remote patient monitoring, Nelson will play a crucial role in guiding Epitel’s growth as the company continues to transform […]

Read More

Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®

Posted on

SOUTH JORDAN, Utah, July 01, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million. EndoGastric Solutions’ EsophyX® Z+ device delivers a durable, minimally invasive non-pharmacological treatment […]

Read More

bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini

Posted on

Marcy-l’Étoile (France), June 26th, 2024 – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug Administration (FDA) Special 510(k) clearance and CLIA-waiver (Clinical Laboratory Improvement Amendments). The COVID-19 pandemic demonstrated the need for healthcare professionals to […]

Read More

Foldax® Reports Positive Clinical Results for TRIA Mitral Surgical Heart Valve Using Novel LifePolymer Material

Posted on

SALT LAKE CITY – June 11, 2024 – Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced positive 30-day results from a prospective, multicenter, single-arm, clinical study of the TRIA™ mitral surgical heart valve with LifePolymer™ conducted in India. At 30 days following surgery, TRIA demonstrated favorable safety and hemodynamics, […]

Read More

Canary Speech Secures $13 Million in Series A Funding

Posted on

Led by Cortes Capital, LLC, Sorenson Communications, LLC., SMK (Japan), and Hackensack Meridian Health, Series A funding expands the AI-driven capabilities of the groundbreaking vocal biomarker health tech company PROVO, Utah, June 12, 2024 /PRNewswire/ — Canary Speech, Inc. (Canary), the leading AI-powered voice biomarker health tech company, has secured a $13 million Series A […]

Read More

Governor Cox Visits BD

SANDY, UTAH, June 6, 2024—Today Governor Spencer Cox visited BD’s Sandy campus to meet with company executives and participate in a town hall meeting with BD employees. Cox’s visit began by listening to a brief presentation about BD’s local and global impact to both patients and the Utah economy by Jeff Stevens, BD’s vice president/general […]

Read More

Utah Gathers at BIO International 2024 in San Diego

BioUtah and its Utah consortium made their mark this week at the BIO International Conference, hosting a Utah Pavillion to promote the state’s fast-growing life sciences industry. The conference, held in San Diego, CA. drew appproximately 19,000 attendees. The Utah delegation included BioUtah, Utah companies, the Governor’s Office of Economic Development, the Unversity of Utah’s […]

Read More

EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections

Posted on

Major Milestone for EVŌQ Nano’s Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases   SALT LAKE CITY, Utah, (May 15, 2024) — EVŌQ Bio, a wholly-owned subsidiary of EVŌQ Nano, today announced the successful completion of a Pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) […]

Read More